BACE1 and Cognitive impairment: Some studies showed that some compounds could mitigate amyloidogenesis and cognitive impairment via inhibiting the NFKB signal pathway to reduce the activity of BACE1 (Choi et al., 2012; Satomoto et al., 2018).